To date, the mainstay of treatment for BIA-ALCL is implant removal with enbloc capsulectomy. BIA-ALCL is typically associated with an indolent course and favorable prognosis.A multidisciplinary team and an early diagnosis are essential for proper patient and disease management. To date, ...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): Quantifying the direct economic costs of post-treatment radiological surveillance. e19574 Background: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) was recognised by the WHO in 2016 as a rare sub-type of perip...
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCLdoi:10.1016/j.breast.2022.11.009BIA-ALCLAnaplastic large cell lymphomaALCLBreast cancerBreast implantsBreast reconstructionShared strategies and correct information are essential to guide physicians in the ...
Breast Reconstruction with Inferior Flap and Fat Transfer as Curative Treatment for BIA-ALCLdoi:10.1007/978-3-030-77455-4_78Breast augmentation with implants is one of the most commonly performed plastic surgical procedures, but has potential complications—asymmetry, implant displacement, rippling and ...
Twenty key opinion leaders in the field of plastic surgery from all over the world have been invited to express and discuss their opinion about some key questions on BIA-ALCL, trying to reach a consensus about BIA-ALCL cause, pathogenesis, diagnosis, and treatment in light of the actual best...
In addition, in its early stages, when most of patients are diagnosed, the lymphoproliferative condition has a very good prognosis, requiring no additional treatment.1 The physician must inform the patient of all risks, particularly the risks of all events that may require implant remov...
The aim of this study was to assess the longer-term oncological outcomes of patients receiving multidisciplinary treatment for BIA-ALCL.MethodsThis was a retrospective cohort study of BIA-ALCL patients treated at a tertiary referral unit. The data are presented using simple descriptive statistics....
the world and more than 1,685,471 breast augmentations are performed annually worldwide, for this reason, it is crucial that every plastic and reconstructive surgeon knows in detail the genetic bases, associated risk factors, clinical features, diagnostic approach and timely treatment of BIA-ALCL....
Identifying the various factors involved in these PPAR纬 related pathways and the correlation between them will lead to the development of the prognosis of breast reconstruction and the diagnosis and treatment of BIA-ALCL.Sanyeowool AnJeong Hyun Ha...
No adjuvant treatment was deemed necessary and a repeat PET-CT will be performed for surveillance. Conclusions: BIA-ALCL poses a medical challenge due to increasing use of implants for reconstructive and cosmetic procedures. Patients usually present with delayed onset of seroma or palpable masses. ...